Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
152 Ergebnisse
| LX7L73 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 129,342 | 129,342 | 2,261 | 33,329 % | - | Lang & Schwarz | ||
| LX7MTN | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 132,365 | 132,365 | 2,337 | 31,771 % | - | Lang & Schwarz | ||
| LX83G4 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 190,152 | 190,152 | 6,855 | 1,983 % | - | Lang & Schwarz | ||
| LX83G6 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 188,096 | 188,096 | 6,467 | 3,043 % | - | Lang & Schwarz | ||
| LX8MKV | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 137,447 | 137,447 | 2,487 | 29,151 % | - | Lang & Schwarz | ||
| LX8NHB | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 142,527 | 142,527 | 2,658 | 26,532 % | - | Lang & Schwarz | ||
| LX8NHD | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 139,576 | 139,576 | 2,570 | 28,054 % | - | Lang & Schwarz | ||
| LX8Q1V | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 149,688 | 149,688 | 2,922 | 22,841 % | - | Lang & Schwarz | ||
| LX8Q1X | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 144,593 | 144,593 | 2,736 | 25,468 % | - | Lang & Schwarz | ||
| LX8SEU | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 147,596 | 147,596 | 2,853 | 23,920 % | - | Lang & Schwarz | ||
| LX8SEV | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 152,689 | 152,689 | 3,129 | 21,294 % | - | Lang & Schwarz | ||
| LX8UB0 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 157,753 | 157,753 | 4,326 | 18,684 % | - | Lang & Schwarz | ||
| LX8UB1 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 154,751 | 154,751 | 3,165 | 20,231 % | - | Lang & Schwarz | ||
| LX8XX0 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 164,871 | 164,871 | 3,760 | 15,015 % | - | Lang & Schwarz | ||
| LX8XX3 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 162,801 | 162,801 | 3,593 | 16,082 % | - | Lang & Schwarz | ||
| LX8XXX | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 169,945 | 169,945 | 5,785 | 12,400 % | - | Lang & Schwarz | ||
| LX8XXY | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 167,875 | 167,875 | 3,959 | 13,467 % | - | Lang & Schwarz | ||
| LX8XYB | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 159,797 | 159,797 | 3,464 | 17,631 % | - | Lang & Schwarz | ||
| LX8YT9 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 183,062 | 183,062 | 5,543 | 5,638 % | - | Lang & Schwarz | ||
| LX8YUB | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 180,059 | 180,059 | 5,215 | 7,186 % | - | Lang & Schwarz | ||
| LX8YUC | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 177,989 | 177,989 | 4,850 | 8,253 % | - | Lang & Schwarz | ||
| LX8YUD | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 174,986 | 174,986 | 4,619 | 9,801 % | - | Lang & Schwarz | ||
| LX8YUE | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 172,916 | 172,916 | 4,409 | 10,868 % | - | Lang & Schwarz | ||
| LX9BP3 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 185,072 | 185,072 | 5,861 | 4,602 % | - | Lang & Schwarz | ||
| LX9CS8 | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 193,106 | 193,106 | - | 0,461 % | - | Lang & Schwarz | ||
| LX9DEG | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 198,111 | 198,111 | - | -2,119 % | - | Lang & Schwarz | ||
| LX9DEH | Axsome Therapeutics Inc./KO/Call [endlos]/LuS | - | - | call | Axsome Therapeutics Inc. | 195,159 | 195,159 | - | -0,597 % | - | Lang & Schwarz | ||
| MB01N9 |  | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 43,344 | 56,350 | 1,215 | 76,219 % | - | Morgan Stanley | |
| MB0VSK | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 53,934 | 70,120 | 1,285 | 70,407 % | - | Morgan Stanley | |
| MB3QK3 | | Axsome Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Axsome Therapeutics Inc. | 166,260 | 166,260 | 4,026 | 29,833 % | - | Morgan Stanley | |
| MB6NLB | | Axsome Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Axsome Therapeutics Inc. | 177,345 | 177,345 | 5,065 | 25,155 % | - | Morgan Stanley | |
| MD6HV2 | | Axsome Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Axsome Therapeutics Inc. | 147,787 | 147,787 | 3,006 | 37,629 % | - | Morgan Stanley | |
| ME6CR6 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 58,179 | 75,640 | 1,321 | 68,078 % | - | Morgan Stanley | |
| MG23NX | | Axsome Therapeutics Inc./Faktor/Long [6]/MS | - | - | call | Axsome Therapeutics Inc. | 184,742 | 184,742 | 6,155 | 22,034 % | - | Morgan Stanley | |
| MG2XYQ | | Axsome Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Axsome Therapeutics Inc. | 166,267 | 166,267 | 4,026 | 29,830 % | - | Morgan Stanley | |
| MJ42F0 | | Axsome Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Axsome Therapeutics Inc. | 110,845 | 110,845 | 1,997 | 53,220 % | - | Morgan Stanley | |
| MJ7VDB | | Axsome Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Axsome Therapeutics Inc. | 177,352 | 177,352 | 5,055 | 25,152 % | - | Morgan Stanley | |
| MJ8AZ2 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 70,124 | 91,170 | 1,405 | 61,524 % | - | Morgan Stanley | |
| MM1NMC | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 83,399 | 108,420 | 1,537 | 54,244 % | - | Morgan Stanley | |
| MM65CU | | Axsome Therapeutics Inc./Faktor/Short [3]/MS | - | - | put | Axsome Therapeutics Inc. | 295,513 | 295,513 | 2,845 | 24,715 % | - | Morgan Stanley | |
| MM66R0 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 98,216 | 127,690 | 1,706 | 46,111 % | - | Morgan Stanley | |
| MM8V6F | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 113,449 | 147,490 | 1,902 | 37,755 % | - | Morgan Stanley | |
| MN121F | | Axsome Therapeutics Inc./Faktor/Short [2]/MS | - | - | put | Axsome Therapeutics Inc. | 332,452 | 332,452 | 1,930 | 40,305 % | - | Morgan Stanley | |
| MN34K8 | | Axsome Therapeutics Inc./Faktor/Short [5]/MS | - | - | put | Axsome Therapeutics Inc. | 265,961 | 265,961 | 4,649 | 12,244 % | - | Morgan Stanley | |
| MN3YJ7 | | Axsome Therapeutics Inc./Faktor/Short [4]/MS | - | - | put | Axsome Therapeutics Inc. | 277,043 | 277,043 | - | 16,920 % | - | Morgan Stanley | |
| MN7S6M | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 125,797 | 163,540 | 2,288 | 30,981 % | - | Morgan Stanley | |
| MN95J8 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 156,500 | 203,460 | 2,881 | 14,134 % | - | Morgan Stanley | |
| MN96FF | | Axsome Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Axsome Therapeutics Inc. | 177,352 | 177,352 | - | 25,152 % | - | Morgan Stanley | |
| MR0JY3 | | Axsome Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Axsome Therapeutics Inc. | 110,845 | 110,845 | - | 53,220 % | - | Morgan Stanley | |
| MR1XPR | | Axsome Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Axsome Therapeutics Inc. | 147,793 | 147,793 | - | 37,627 % | - | Morgan Stanley |